AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12517329
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine
Trial: 30098962
Drug: No low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: No low-dose dopamine
Trial: 26194361
Drug: Carboplatin/taxane chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin/taxane chemotherapy
Trial: 20671038
Drug: β‐alanine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β‐alanine (5 g/day)
Trial: 10931579
Drug: MnDPDP injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MnDPDP injection (5 micromol/kg)
Trial: 8154130
Drug: Heparin-induced extracorporeal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-induced extracorporeal LDL precipitation (HELP)
Trial: 27056964
Drug: Transcatheter patent
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcatheter patent foramen ovale closure plus antiplatelet therapy
Trial: 24013574
Drug: Dextromethorphan (DM)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DM) alone at 60 mg on day 1
Trial: 24013574
Drug: Panobinostat at
RxNorm normalized name: Panobinostat
DrugBank: Panobinostat (DB06603)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Panobinostat at 20 mg alone on days 3 and 5
Trial: 24013574
Drug: Dextromethorphan (DM)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DM) and panobinostat co-administered on day 8
Trial: 8814419
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (CoQ) 150 mg per day for 6 months
Trial: 1306815
Drug: Nitrendipine (active
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (active treatment group, 45 patients)
Trial: 2867800
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg thiotepa instillation at the time of primary treatment
Trial: 2867800
Drug: Instillations of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instillations of thiotepa at 3‐monthly intervals for a year
Trial: 19752319
Drug: Dronedarone 400
RxNorm normalized name: dronedarone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronedarone 400 mg BID
Trial: 25134972
Drug: Propafenone 150
RxNorm normalized name: propafenone 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 150 mg TID
Trial: 1385929
Drug: Loratadine 10
RxNorm normalized name: loratadine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine 10 mg (5 mg for patients ≤30 kg)
Trial: 1385929
Drug: Astemizole 2
RxNorm normalized name: astemizole 2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole 2 mg/10 kg body weight
Trial: 6502473
Drug: Antacid regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid regimen administered for three full days
Trial: 6502473
Drug: Theophylline therapy
RxNorm normalized name: Theophylline
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Theophylline therapy with antacids
Trial: 6502473
Drug: Control (theophylline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (theophylline therapy without antacids)
Trial: 30291402
Drug: Very-low-nicotine-content cigarettes
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Very-low-nicotine-content cigarettes (VLNCCs; 1 mg nicotine/g tobacco)
Trial: 30291402
Drug: Normal-nicotine-content cigarettes
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Normal-nicotine-content cigarettes (NNCCs; 16 mg/g)
Trial: 24214217
Drug: sipoglitazar (8,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sipoglitazar (8, 16, 32, or 64 mg once daily; 16 or 32 mg twice daily)
Trial: 24214217
Drug: rosiglitazone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosiglitazone (8 mg once daily)
Trial: 10669372
Drug: Meningococcal C
RxNorm normalized name: meningococcal conjugate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meningococcal C conjugate (MCC) vaccine
Trial: 11865832
Drug: Pentoxifylline (PXF)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PXF) 2400 mg (four 600‐mg tablets daily) for 10 days
Trial: 1700873
Drug: Colloid (hydroxy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloid (hydroxy ethyl starch) and electrolyte solution (group COL)
Trial: 31873746
Drug: Cabotegravir LA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabotegravir LA 400 mg + Rilpivirine LA 600 mg IM every 4 weeks
Trial: 31873746
Drug: Cabotegravir LA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabotegravir LA 600 mg + Rilpivirine LA 900 mg IM every 8 weeks
Trial: 22008041
Drug: Endoscopic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic injection treatment
Trial: 14999237
Drug: Self-administration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administration of the International Prostate Symptom Score (IPSS) questionnaire.
Trial: 14999237
Drug: Physician administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physician administration of the International Prostate Symptom Score (IPSS) questionnaire.
Trial: 11260005
Drug: Calcitriol 3
RxNorm normalized name: CALCITRIOL 3MCG/GM OINT,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol 3 microg g-1 ointment plus UVB phototherapy
Trial: 9554807
Drug: losartan, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan, 50 mg for 14 days
Trial: 7748145
Drug: Sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1 g one hour before breakfast and dinner)
Trial: 3058398
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate ointment (0.1 percent), applied once daily
Trial: 3058398
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate cream (0.1 percent), applied once daily
Trial: 3058398
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate ointment and cream (0.1 percent)
Trial: 3058398
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide ointment (0.025 percent), applied three times daily
Trial: 3058398
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide ointment (0.1 percent), applied twice daily
Trial: 3058398
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide cream (0.025 percent), applied three times daily
Trial: 3058398
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide cream (0.1 percent), applied twice daily
Trial: 31680378
Drug: Eshnan (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eshnan (500 mg, three tablets taken orally after each meal for 2 months)
Trial: 31680378
Drug: Placebo (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (three tablets taken orally after each meal for 2 months)
Trial: 29551324
Drug: Motivational outreach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational outreach call, multisession telephone counseling, and assistance with obtaining nicotine replacement therapy
Trial: 29551324
Drug: Usual Veterans
RxNorm normalized name: benzalkonium chloride Topical Foam [Veteran Shield 24]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual Veterans Administration smoking services
Trial: 23255783
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of immunoglobulin A antibodies to Epstein‐Barr virus capsid antigen and nuclear antigen‐1 by enzyme‐linked immunosorbent assay and indirect mirror examination in the nasopharynx and/or lymphatic palpation (IMLP)
Trial: 1606996
Drug: Oxazepam 10
RxNorm normalized name: oxazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam 10 mg
Trial: 9065993
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) (n = 28)
Trial: 9065993
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) (n = 32)
Trial: 30285811
Drug: Single use
RxNorm normalized name: CLIN Single Use Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single use negative pressure wound therapy (sNPWT)
Trial: 24212478
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg 0.5% isobaric levobupivacaine
Trial: 24212478
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg 0.5% isobaric bupivacaine
Trial: 15837439
Drug: Subjects lacking
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subjects lacking strong preferences for treatment
Trial: 15837439
Drug: Subjects with
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subjects with strong preferences for treatment
Trial: 1759004
Drug: Salbutamol aerosol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol aerosol 400 micrograms before and 200 micrograms 2-hourly after challenge
Trial: 1759004
Drug: Oral terfenadine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terfenadine 120 mg 2 h before and 10 h after challenge
Trial: 1759004
Drug: No medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medication or antigen challenge
Trial: 30879831
Drug: XEN® Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XEN® Gel Stent as a stand-alone procedure
Trial: 30879831
Drug: XEN® Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XEN® Gel Stent in combined surgery
Trial: 30683533
Drug: XEN® Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XEN® Gel Stent (both procedures)
Trial: 28374714
Drug: Collost (medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collost (medical device) in addition to standard therapy
Trial: 23705925
Drug: Cinacalcet +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet + oral vitamin D (n = 33)
Trial: 23705925
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D alone (control group, n = 33)
Trial: 2488104
Drug: Controlled-release metoprolol
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release metoprolol (CR) 100 mg
Trial: 2488104
Drug: Controlled-release metoprolol
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release metoprolol (CR) 200 mg
Trial: 2488104
Drug: Metoprolol Durules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol Durules 200 mg
Trial: 2488104
Drug: Metoprolol plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol plain tablet 100 mg
Trial: 13418
Drug: TRH administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH administered to 6 patients with endogenous depressions
Trial: 13418
Drug: MIF-1 60
RxNorm normalized name: Immunoglobulin g1-kappa, anti-(homo sapiens mif (macrophage migration inhibitory factor, glycosylation-inhibiting factor, glif, gif)), homo sapiens monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIF-1 60 mg per day for 6 days
Trial: 13418
Drug: MIF-1 150
RxNorm normalized name: Immunoglobulin g1-kappa, anti-(homo sapiens mif (macrophage migration inhibitory factor, glycosylation-inhibiting factor, glif, gif)), homo sapiens monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIF-1 150 mg per day
Trial: 13418
Drug: MIF-1 75
RxNorm normalized name: Immunoglobulin g1-kappa, anti-(homo sapiens mif (macrophage migration inhibitory factor, glycosylation-inhibiting factor, glif, gif)), homo sapiens monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIF-1 75 mg per day
Trial: 13418
Drug: MIF-1 750
RxNorm normalized name: Immunoglobulin g1-kappa, anti-(homo sapiens mif (macrophage migration inhibitory factor, glycosylation-inhibiting factor, glif, gif)), homo sapiens monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIF-1 750 mg per day
Trial: 13418
Drug: LHRH 700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LHRH 700 mug or saline once daily for 3 consecutive days per week
Trial: 13418
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of LHRH in a single-blinded study
Trial: 31647470
Drug: 23vPPV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23vPPV vaccine
Trial: 23936304
Drug: PCT guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCT guided treatment
Trial: 19855285
Drug: Intermittent therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent therapy (IT)
Trial: 11280679
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (500 microg Se daily for 5 days)
Trial: 3350203
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg aspirin daily
Trial: 3350203
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg dipyridamole three times daily
Trial: 30767637
Drug: Botanically-enriched topical
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Botanically-enriched topical salve (BES)
Trial: 28225483
Drug: MTHFR genotype
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTHFR genotype (CC/CT)
Trial: 21575959
Drug: Oral tadalafil
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tadalafil 20 mg plus low dose intracavernous injection of vasoactive agents (15 mg papaverine plus 20 mg tadalafil)
Trial: 21575959
Drug: Oral tadalafil
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tadalafil 20 mg
Trial: 21575959
Drug: Intracavernous injection
RxNorm normalized name: Bivalirudin 250 mg INTRACAVERNOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernous injection mode (30 to 60 mg papaverine)
Trial: 20015432
Drug: Cefradine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefradine (oral administration)
Trial: 16413010
Drug: Warfarin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (mean daily dose 3.11±1.62 mg)
Trial: 14652518
Drug: CONFOR‐Med mattress/cushion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CONFOR‐Med mattress/cushion combination
Trial: 14652518
Drug: Standard mattress/cushion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard mattress/cushion combination
Trial: 11126272
Drug: iloprost infusion
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: iloprost infusion (1 ng/kg per minute) for 24 h
Trial: 19136144
Drug: Long-acting opioid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting opioid analgesics
Trial: 11693062
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha as maintenance treatment
Trial: 11693062
Drug: Cyclically alternating
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclically alternating interferon alpha and dexamethasone treatment
Trial: 8434322
Drug: 2 mL
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mL of standard-dose chymopapain (4,000 units)
Trial: 8434322
Drug: 2 mL
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mL of low-dose chymopapain (2,000 units)
Trial: 26817117
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment of NASH (Ursodeoxycholic acid 15 mg/kg once a day, Atorvastatin 20 mg at night, Vitamin E 800 IU/day for 12 months)
Trial: 26817117
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg/day in addition to standard treatment for 12 months
Trial: 18276852
Drug: NK1R antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: NK1R antagonist (LY686017)
Trial: 16982493
Drug: C-reactive protein
RxNorm normalized name: C-reactive protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-reactive protein (CRP) > 1.0 mg/dl
Trial: 11088095
Drug: 17‐beta estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17‐beta estradiol with 0.5 mg of norethindrone acetate
Trial: 11088095
Drug: 17‐beta estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17‐beta estradiol with 0.25 mg of norethindrone acetate
Trial: 16482084
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of 17‐beta estradiol
Trial: 27071140
Drug: e-PRP injection
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: e-PRP injection
Trial: 25398137
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose Vacc-4x
Trial: 25398137
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose Vacc-4x
Trial: 25398137
Drug: Vacc-4x (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vacc-4x (all doses)
Trial: 24765899
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (ITM) 0.1 mg
Trial: 23872462
Drug: Local infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local infiltration analgesia (LIA) with ropivacaine 300 mg + ketorolac 30 mg + epinephrine 0.5 mg
Trial: 20374662
Drug: Sports chiropractic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sports chiropractic manual therapy intervention
Trial: 18491137
Drug: Maximum androgen
RxNorm normalized name: Maximum-H
DrugBank: Hydrocortisone (DB00741)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Maximum androgen blockade (MAB) with bicalutamide (Casodex) 80 mg plus LHRHa
Trial: 18491137
Drug: LHRHa monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LHRHa monotherapy
Trial: 12563210
Drug: Duplex ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duplex ultrasound scan with ultrasound scan contrast agent
Trial: 2862087
Drug: Basal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Basal insulin supplement (ultralente insulin)
Trial: 28135023
Drug: Paracetamol only
RxNorm normalized name: Paracetamol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol only
Trial: 29017585
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of paracetamol and ibuprofen
Trial: 30803141
Drug: Intra-oral camera
RxNorm normalized name: Calmera Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-oral camera (IOC)
Trial: 14628599
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg once a day for 3 days
Trial: 14628599
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment with indwelling catheter and oral antibiotics)
Trial: 10369847
Drug: Ibutilide pretreatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibutilide pretreatment (1 mg)